Clinical Trial Update: Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer [Phase 2]

View source ↗

Summary

Status update on a Phase 2 trial evaluating avelumab with or without cetuximab in advanced skin squamous cell carcinoma, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer
• Skin Squamous Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• Cetuximab (cetuximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Skin Squamous Cell Carcinoma, Metastatic Skin Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING